Avricore Health's HealthTab™ Expands to 70 New Pharmacy Sites in North East London NHS Program

summarizeSummary

Avricore Health announced a significant expansion of its HealthTab™ platform to 70 new pharmacy sites in North East London, building on successful NHS programs and demonstrating strong market traction.

check_boxKey Events

• HealthTab™ Platform Expansion

  Avricore Health announced the planned expansion of its HealthTab™ platform to an additional 70 community pharmacy sites across North East London.

• NHS Program Success

  The expansion builds on the success of its NHS-linked cardiovascular programs delivered in collaboration with Barts Health NHS Trust, attracting national attention including BBC News coverage.

• Strategic UK Focus and Scalability

  This deployment reinforces Avricore's strategic focus on the UK market and demonstrates the scalability of HealthTab™ within complex NHS environments, positioning it for further growth.

auto_awesomeAnalysis

This filing reports a significant operational expansion for Avricore Health, deploying its HealthTab™ platform to 70 additional community pharmacy sites in North East London. This move reinforces the company's strategic focus on the UK and demonstrates the scalability of its solution within the complex NHS environment. The expansion, building on successful NHS-linked cardiovascular programs, is a strong positive signal, especially following the substantial revenue decline and comprehensive loss reported in the January 12, 2026 6-K filing. This development indicates growing adoption and potential for future revenue generation, which is critical for the company's financial health and long-term viability.